KBY Biotech Indexv0.0.34
Search
← Pipeline|Zanusertib

Zanusertib

Approved
ABB-8914
By AbbVie
Source: Trial-derived·Trials: 1
Modality
Small Molecule
MOA
KRASG12Di
Target
PCSK9
Pathway
Notch
AMLRett
Development Pipeline
Preclinical
~Feb 2014
→ ~May 2015
Phase 1
~Aug 2015
→ ~Nov 2016
Phase 2
~Feb 2017
→ ~May 2018
Phase 3
~Aug 2018
→ ~Nov 2019
NDA/BLA
~Feb 2020
→ ~May 2021
Approved
Aug 2021
ApprovedCurrent
NCT03883596
366 pts·AML
2021-08→TBD·Recruiting
366 total pts1 indication
CompletedCurrentUpcoming
Trial Timeline
Approved
Recruit…
Recruiting|StartCompletionToday
Trials (1)
NCTPhaseIndicationStatusNEP
NCT03883596ApprovedAMLRecruiting366DAS28
Competitors (10)
DrugCompanyPhaseTargetMOA
DoxarasimodMerck & CoNDA/BLAFGFRKRASG12Di
PexarelsinAstraZenecaPhase 1DLL3KRASG12Di
IvotuximabGSKNDA/BLAGIP-RKRASG12Di
GIL-4361Gilead SciencesPreclinicalPCSK9STINGag
REG-2172RegeneronPhase 1/2PCSK9Anti-Tau
BMR-8377BioMarinPhase 1/2PCSK9BTKi
CapifutibatinibIncytePhase 3PCSK9BCL-2i
INC-5849IncytePhase 2PCSK9STINGag
TalatapinarofSamsung BiologicsPhase 1/2PCSK9SHP2i
TerarasimodKrystal BiotechPhase 1/2PI3KαKRASG12Di